Back to Search
KAREN SLOBOD, MD
MD
Pediatric Infectious Diseases Physician
NPI: 1477556041Individual
Specialties, Licenses & Credentials
Pediatric Infectious Diseases PhysicianPrimary
Pediatrics — Pediatric Infectious Diseases
Code: 2080P0208X
24213(TN)
Research & Publications (20)
Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?
PMID 15860130·AIDS Res Ther·2005
8-other
HIV vaccines: brief review and discussion of future directions.
PMID 16026246·Expert Rev Vaccines·2005
6-review
Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults.
PMID 15297072·Vaccine·2004
3-trial
Subcutaneous administration of a recombinant vaccinia virus vaccine expressing multiple envelopes of HIV-1.
PMID 14735404·Eur J Clin Microbiol Infect Dis·2004
4-observational
T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.
PMID 11817326·Immunol Res·2001
4-observational
Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.
PMID 19241253·Int Rev Immunol·2009
6-review
Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
PMID 19200447·Vaccine·2009
7-preclinical
HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.
PMID 17981574·Front Biosci·2008
6-review
First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants.
PMID 18090404·AIDS·2008
3-trial
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
PMID 18499307·Vaccine·2008
7-preclinical
HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations.
PMID 17411381·AIDS Res Hum Retroviruses·2007
7-preclinical
Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.
PMID 18037543·Vaccine·2007
7-preclinical
A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein.
PMID 17652379·J Virol·2007
7-preclinical
Individual HIV type 1 envelope-specific T cell responses and epitopes do not segregate by virus subtype.
PMID 16478402·AIDS Res Hum Retroviruses·2006
8-other
Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.
PMID 16035938·Viral Immunol·2005
6-review
Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.
PMID 16095768·Vaccine·2005
7-preclinical
T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry.
PMID 15725756·AIDS Res Hum Retroviruses·2005
7-preclinical
Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy.
PMID 15752831·Vaccine·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, 332 N LAUDERDALE ST., MS 0515
MEMPHIS, TN 38105 - Phone
- (901) 495-3006
Quick Facts
- NPI
- 1477556041
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile